-
Adam J, Habeshaw T, Kirk J.
Response rate of malignant melanoma to large fraction irradiation.
Br J Radiol 1982;55:605-607.
-
Agarwala SS et al.
Temozolomide for the treatment of brain metastases associated with metastatic melanoma: A phase II study.
J Clin Oncol 2004;11:2101-2107.
-
Amer M, Al-Sarraf M, Vaitkevicius V.
Clinical presentation, natural history and prognostic factos in advanced malignant melanoma.
Surg Gynecol Obstet 1979;14:687-692.
-
Amer MH et al.
Malignant melanoma and central nervous system metastases: Incidence, diagnosis, treatment and survival.
Cancer 1978;42:660-668.
-
Anrews DW et al.
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RT06 9508 randomized trial.
Lancet 2004;363:1665-1672.
-
Arcangeli G et al.
Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration.
Int J Radiat Oncol Biol Phys 1998;42:1119-26.
-
Brega K et al.
Surgical treatment of brain metastases in malignant melanoma.
Cancer 1990;66:2105-2110.
-
Brock CS et al.
Phase I trial of temozolomide using an extended continous oral schedule.
Cancer Res 1998;58:4363-4367.
-
Brocker EB et al., Fotemustine given simultaneously with total brain irradiation in multiple brain metastases of malignant melanoma: Report on a pilot study.
Melanoma Res 1996;6:399-401.
-
Budman D, Camacho E, Wittes R.
The current causes of death in patients with malignant melanoma.
Eur J Cancer 1978;14:327-330.
-
Coleman RE.
Bisphosphonates: clinical experience.
Oncologist 9 2004;14-27.
-
Dhopapkar M et al.
Phase I trial of temozolomide in patients with advanced cancer.
Clin Cancer Res 1997;3:1093-1100.
-
Doss L, Memula M.
The radioresponsiveness of melanoma.
Int J Radiat Oncol Biol Phys 1985;8:1131-1134.
-
Douglas JG, Margolin KA.
The treatment of brain metastases from malignant melanoma.
Semin Oncol 2002;29:518-524.
-
Falkson CI, Falkson G, Falkson HC.
Phase II trial of fotemustine in patients with metastatic malignant melanoma.
Invest New Drugs 1994;12:251-254.
-
Flickinger J et al.
Radiosurgery: Its role in brain metastasis management.
Neurosurg Clin North Am 1996;7:497-504.
-
Gaspar L et al.
Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.
Radiat Oncol Biol Phys 1997;37:745-751.
-
Geara F, Ang K.
Radiation therapy for malignant melanoma.
Surg Clin North Am 1996;76:1383-1399.
-
Geiger M et al.
Response of intracranial melanoma metastases to sterotactic radiosurgery.
Radiat Oncol Investig 1997;5:72-80.
-
Grob J et al.
Radiosurgery without whole brain radiotherapy in melanoma brain metastases.
Eur J Cancer 1998;34:1187-1192.
-
Hammond LA et al.
Phase I and pharmacokinetics study of temozolomide on a dailyfor-5-days schedule in patients with advanced solid malignancies.
J Clin Oncol 1999;17:2604-2613.
-
Hwu WJ et al.
Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma.
J Clin Oncol 2003;21:3351-3356.
-
Jacquillat C et al.
Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases.
Cancer 1990;66:873-878.
-
Khayat D et al.
Fotemustine in the treatment of brain primary tumors and metastases.
Cancer Invest 1994;12:414-420.
-
Kleeberg UR et al.
Palliative therapy of melanoma patients with fotemustine. Inverse relationship between tumour load and treatment effectiveness. A multicentre phase II trial of the EORTC-Melanoma Cooperation Group (MCG).
Melanoma Res 1995;5:195-200.
-
Konefal J, Emami B, Pilepich M.
Analysis of dose fractionation in the palliation of metastases from malignant melanoma.
Cancer 1988;61:243-246.
-
Leksell L.
The stereotaxic method and radiosurgery of the brain.
Acta Chir Scand 1951;102:316-319.
-
Loeffler J, Barker F, Chapman P.
Role of radiosurgery in the management of central nervous system metastases.
Cancer Chemother Pharmacol 1999;43:11-14.
-
Margolin K et al.
Temozolomide and whole brain irradiation in melanoma metastatic to the brain: A phase II trial of the Cytokine Working Group.
J Cancer Res Clin Oncol 2002;128:213-218.
-
McQuay HJ et al.
Radiotherapy for the palliation of painful bone metastases.
Cochrane Database Syst Rev 2: CD001793, 2000.
-
Mintz AH et al.
A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis.
Cancer 1996;78:1470-1476.
-
Mitchel MS.
Relapse in the central nervous system in melanoma patients successfully trated with biomodulators.
J Clin Oncol 1989;7:1701-1709.
-
Mornax F et al.
A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma.
Mel Res 2003;13:97-103.
-
Newlands ES et al.
Temozolomide: Drug scheduling in vivo and in combination with radiation.
Proc Am Soc Clin Oncol 1997;16:393a (abstract 1403).
-
Overgaard J.
The role of radiotherapy in recurrend and metastatic malignant melanoma: A clinical radiobiological study.
Int J Radiat Oncol Biol Phys 1986;12:867-872.
-
Overgaard J.
Radiation treatment of malignant melanoma.
Int J Radiat Oncol Biol Phys 1980;6:41-44.
-
Overgaard J, von der Maase H, Overgaard M.
A randomized study comparing two highdose per fraction radiation schedules in recurrent or metastatic malignant melanoma.
Int J Radiat Oncol Biol Phys 1985;11:1837-1839.
-
Patchell RA et al.
A randomized trial of surgery in the treatment of single metastases to the brain.
N Engl J Med 1990;322:494-500.
-
Patel M et al.
Plasma and cerebrospinal fluid pharmacokinetics of temozolomide.
Proc Am Soc Clin Oncol 1995;14:461 (abstract 1485).
-
Pirzkall AJ D et al.
Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases.
J Clin Oncol 1998;16:3563-3569.
-
Radbill AE et al.
Initial treatment of melanoma brain metastases using gamma knife radiosurgery.
Cancer 2004;101:825-833.
-
Sampaio EP et al.
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.
J Exp Med 1991;173:699-703.
-
Sampson J et al.
Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.
J Neurosurg 1998;88:11-20.
-
Sause W et al.
Fraction size in external beam radiation therapy in the treatment of melanoma.
Int J Radiat Oncol Biol Phys 1991;20:429-432.
-
Sause W et al.
Solitary brain metastasis: Results of an RTOG/SWOG protocol evaluation surgery + RT versus RT alone.
Am J Clin Oncol 1990;13:427-432.
-
Schoeggl A et al.
Prognostic factor analysis for multiple brain metastases after gamma knife radiosurgery: Results in 97 patients.
J Neurooncol 1999;42:169-175.
-
Seegenschmiedt MH et al.
Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
Int J Radiat Oncol Biol Phys. 1999;44:607-18.
-
Selek U et al.
Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
Int J Radiat Oncol Biol Phys 2004;59:1097-1106.
-
Seung S et al.
Gamma knife radiosurgery for malignant melanoma brain metastases.
Cancer J Sci Am 1998;4:103-109.
-
Shaw E et al.
Single dose radiosurgery treatment of reccurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05.
Int J Radiat Oncol Biol Phys 2000;47:291-298.
-
Shiau C et al.
Radiosurgery for brain metastases: Relationship of dose and pattern of enhancement to local control.
Int J Radiat Oncol Biol Phys 1997;37:375-383.
-
Siena S et al.
A phase II study of temozolomide therapy for brain metastasis in patients with malignant melanoma, breast cancer and non-small cell lung cancer.
Proc Am Soc Clin Oncol 2003;22:102 (abstract 407).
-
Smalley S et al.
Resection for solitary brain metastasis.
J Neurosurg 1992;77:531-540.
-
Somoza S et al.
Sterotactic radiosurgery for cerebral metastastic melanoma.
J Neurosurg 1993;79:661-666.
-
Sperduto PW et al.
Stereotactic radiosurgery with whole brain radiation therapy improves survival in patients with brain metastases: Report of Radiation Oncology Group Phase III Study 95-08.
Int J Radiation Biol Physics 2002;54:Plenary 5.
-
Strauss A et al.
Radiation therapy of malignant melanomas: An evaluation of clinically used fractionated schemes.
Cancer 1981;47:1262-1266.
-
Stupp R et al.
Daily temozolomide and concomitant radiotherapy followed by adjuvant TMZ for newly diagnosed glioblastoma multiforme: A well-tolerated and promising regimen.
Proc Am Soc Clin Oncol 1999;18:154a (abstract 592).
-
Tonsoni A, Lumachi F, Brandes AA.
Treatment of brain metastases in uncommon tumors.
Expert Rev Anticancer Ther 2004;4:794-793.
-
Vecht CJ et al.
Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993;33:583-590.
-
Williams J et al.
Sterotactic radiosurgery for brain metastses: Comparision of lung carcinoma vs. non-lung tumors.
J Neurooncol 1998;37:79-85.
-
Wronski M, Arbit E.
Surgical treatment of brain metastases from melanoma: A retrospective study of 91 patients.
J Neurosurg 2000;93:9-18.
-
Young R.
Radiosurgery for the treatment of brain metastases.
Semin Surg Oncol 1998;14:70-78.
Bildatlas Hämatologie
Druckversion
ISSN: 2193-6021
Zum Seitenanfang